Polpharma API is a European producer of Active Pharmaceutical Ingredients since 1951 and a CDMO provider, part of Polpharma Group. Headquartered in Poland with over 70 years of experience in process development, scale-up, and cGMP manufacturing. Advancing high potent API capabilities with OEL as low as 10 ng/m3 (OEB 5-6). Expanding into oligonucleotide production with GMP-compliant manufacturing up to 50g batch sizes. Offers cryogenic chemistry capabilities down to -90C. Operates kilo-lab, pilot, and commercial scale with Hastelloy and glass-lined reactors.
High potent API manufacturing (HPAPI), oligonucleotide synthesis and purification, cryogenic chemistry, hazardous chemistry (Grignard, hydrogenation, lithiation), small molecule API process development and commercial manufacturing
1 site worldwide
No reviews available yet.
No documents available.